Dishman Carbogen Amcis Ltd’s wholly-owned subsidiary, CARBOGEN AMCIS AG, has successfully commissioned a new ground-mounted photovoltaic system at its Neuland site in Switzerland. The new solar power plant, with a capacity of 1,200 kWp, comprises 2,448 photovoltaic modules installed on an area of approximately 6,200 m². This development underscores the company's commitment to sustainability and the expansion of renewable energy within its operations.

The facility is designed to be one of the most efficient conventional ground-mounted systems in the Swiss Mittelland region. Ground-mounted photovoltaic systems remain rare in Switzerland, making this a significant installation for an industrial site. The energy generated will be used primarily for on-site consumption, which is expected to sustainably reduce the company's CO2 emissions.

Project Details and Implementation

The project was executed in collaboration with energy and infrastructure partners IWB (Industrielle Werke Basel) and its subsidiary Planeco. These partners were responsible for the planning and implementation of the facility. The construction phase lasted three months, concluding with an official opening ceremony attended by government officials and company representatives.

Strategic Impact

Stephan Fritschi, Chief Executive Officer of CARBOGEN AMCIS, stated that the commissioning represents a targeted investment in a sustainable energy supply. The project is viewed as an important milestone in the company's path to implementing environmental goals. CARBOGEN AMCIS aims to continuously improve energy efficiency and increase the share of renewable energy in its production processes.

CARBOGEN AMCIS is a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company. It is a wholly owned subsidiary of Dishman Carbogen Amcis Ltd .

Dishman Carbogen Amcis Ltd reported a consolidated net profit of ₹97.45 crore for the financial year ended March 31, 2026, a significant increase from ₹3.24 crore in the previous year. The company's board approved the audited financial results for the quarter and year ended March 31, 2026, in a meeting held on May 19, 2026. The statutory auditors, M/s. TR Chadha & Co. LLP, issued an unmodified opinion on the results.

The board approved availing external commercial borrowings (ECB) up to CHF 200 million from promoter group company Aamanya AG, revising the earlier proposed limit of CHF 135 million. The loan proceeds will be utilized to refinance existing external indebtedness and for working capital and capital expenditure requirements. The loan carries an interest rate of SARON plus 400 basis points, currently 4% per annum, with a tenor of 10 years. Additionally, the board passed a resolution to increase the borrowing limits under Section 180(1)(c) of the Companies Act, 2013, from ₹1,700 crores to ₹4,000 crores, subject to shareholder approval.

The board recommended the re-appointment of M/s. TR Chadha & Co. LLP as statutory auditors for a second term of five consecutive years, subject to shareholder approval at the ensuing annual general meeting. The company also announced that it would seek requisite shareholder approval for the ECB proposal and the increase in borrowing limits through an Extra-Ordinary General Meeting.

Consolidated Financial Performance

The company reported a total income from operations of ₹2,931.90 crore for FY26, up from ₹2,711.50 crore in the previous year. Total expenses for the year stood at ₹2,879.14 crore. For the quarter ended March 31, 2026, the company reported a net profit of ₹21.74 crore, compared to a net loss of ₹12.97 crore in the corresponding quarter of the previous year.

Standalone Financial Performance

On a standalone basis, the company reported a net loss of ₹38.40 crore for FY26, compared to a net loss of ₹9.87 crore in the previous year. Total income from operations for the year stood at ₹231.56 crore. For the quarter ended March 31, 2026, the standalone net loss was ₹4.34 crore.

The auditors noted a deviation in one of the India standalone financial covenants related to certain borrowing arrangements as of March 31, 2026. However, the company was in full compliance with financial covenants at the consolidated level. The company had requested and received waivers from certain debenture holders for the standalone deviation.